Inventor · disambiguated record
Louise Kristine Vigsnæs
Also filed as: VIGSNÆS LOUISE KRISTINE
38 granted patents·18 pending applications·74 citations·filing 2015–2022
96Inventor score
Files withGLYCOM AS56
Top patents by PatentIndex Score
56 records- 0196US10780103B2Synthetic composition and method for modulating emotion and mood disordersGLYCOM AS·Filed 2016·Granted Sep 22, 2020·4 cites·10 claims
- 0295US11529364B2Synthetic composition for treating metabolic disordersGLYCOM AS·Filed 2020·Granted Dec 20, 2022·4 cites·20 claims
- 0395US11040049B2Composition comprising HMSs/HMOs and use thereofGLYCOM AS·Filed 2018·Granted Jun 22, 2021·9 cites·16 claims
- 0494US11040050B2Composition comprising HMSs/HMOs and use thereofGLYCOM AS·Filed 2018·Granted Jun 22, 2021·8 cites·15 claims
- 0592US11529365B2Synthetic composition for microbiota modulationGLYCOM AS·Filed 2020·Granted Dec 20, 2022·2 cites·15 claims
- 0692US10857168B2Synthetic composition for microbiota modulationGLYCOM AS·Filed 2017·Granted Dec 8, 2020·5 cites·15 claims
- 0791US11278558B2Synthetic composition for microbiota modulationGLYCOM AS·Filed 2018·Granted Mar 22, 2022·5 cites·20 claims
- 0890US11026959B2Synthetic composition and method for treating irritable bowel syndromeGLYCOM AS·Filed 2018·Granted Jun 8, 2021·9 cites·20 claims
- 0990US10987368B2Synthetic composition for preventing or treating CVDGLYCOM AS·Filed 2016·Granted Apr 27, 2021·4 cites·15 claims
- 1087US10828313B2Synthetic composition for treating metabolic disordersGLYCOM AS·Filed 2015·Granted Nov 10, 2020·5 cites·20 claims
- 1185US11696921B2Synthetic composition for microbiota modulationGLYCOM AS·Filed 2020·Granted Jul 11, 2023·1 cites·16 claims
- 1285US10881674B2Synthetic composition for treating metabolic disordersGLYCOM AS·Filed 2016·Granted Jan 5, 2021·2 cites·12 claims
- 1385US10751354B2Synthetic composition for microbiota modulationGLYCOM AS·Filed 2016·Granted Aug 25, 2020·4 cites·11 claims
- 1484US10835544B2Synthetic composition for regulating satietyGLYCOM AS·Filed 2016·Granted Nov 17, 2020·2 cites·11 claims
- 1583US11224605B2Synthetic compositionGLYCOM AS·Filed 2017·Granted Jan 18, 2022·3 cites·13 claims
- 1680US10864224B2Synthetic composition for treating antibiotic associated complicationsGLYCOM AS·Filed 2016·Granted Dec 15, 2020·3 cites·12 claims
- 1779US11986487B2Mixture of HMOS for treating wheat sensitivityGLYCOM AS·Filed 2022·Granted May 21, 2024·0 cites·19 claims
- 1879US10471084B2Composition and method for treating acute respiratory tract infectionsGLYCOM AS·Filed 2016·Granted Nov 12, 2019·2 cites·18 claims
- 1974US2023119720A1Synthetic composition for treating metabolic disordersGLYCOM AS·Filed 2022·Application pending·0 cites
- 2073US10835545B2Synthetic composition and method for modulating brain function and behaviourGLYCOM AS·Filed 2016·Granted Nov 17, 2020·1 cites·21 claims
- 2172US11291677B2Synthetic composition for microbiota modulationGLYCOM AS·Filed 2018·Granted Apr 5, 2022·1 cites·19 claims
- 2271US11833165B2Synthetic composition and method for treating irritable bowel syndromeGLYCOM AS·Filed 2021·Granted Dec 5, 2023·0 cites·19 claims
- 2370US11452736B2Mixture of HMOs for treating wheat sensitivityGLYCOM AS·Filed 2018·Granted Sep 27, 2022·0 cites·17 claims
- 2469US11896604B2Composition comprising HMSs/HMOs and use thereofGLYCOM AS·Filed 2021·Granted Feb 13, 2024·0 cites·20 claims
- 2569US11896605B2Composition comprising HMSs/HMOs and use thereofGLYCOM AS·Filed 2021·Granted Feb 13, 2024·0 cites·13 claims
- 2669US11491171B2Synthetic composition and method for modulating emotion and mood disordersGLYCOM AS·Filed 2020·Granted Nov 8, 2022·0 cites·18 claims
- 2767US11684630B2Synthetic composition and method for modulating brain function and behaviourGLYCOM AS·Filed 2020·Granted Jun 27, 2023·0 cites·20 claims
- 2867US2022395520A1Compositions comprising hmos, their production and use for the prevention and/or treatment of viral and/or bacterial infectionsGLYCOM AS·Filed 2022·Application pending·0 cites
- 2966US11998558B2Synthetic composition for treating antibiotic associated complicationsGLYCOM AS·Filed 2020·Granted Jun 4, 2024·0 cites·10 claims
- 3065US2020147114A1Composition and method for treating acute respiratory tract infectionsGLYCOM AS·Filed 2019·Application pending·0 cites
- 3165US2022133759A1Synthetic compositionGLYCOM AS·Filed 2022·Application pending·0 cites
- 3264US11890293B2Synthetic composition for treating metabolic disordersGLYCOM AS·Filed 2021·Granted Feb 6, 2024·0 cites·17 claims
- 3364US2022233562A1COMPOSITION COMPRISING HMOs FOR PREVENTING OR REDUCING NOCICEPTIONGLYCOM AS·Filed 2022·Application pending·0 cites
- 3464US2021393657A1Synthetic composition for preventing or treating cvdGLYCOM AS·Filed 2021·Application pending·0 cites
- 3561US2022233561A1Human milk oligosaccharides for use in the treatment of symptoms in a patient suffering from non-coeliac wheat and / or gluten sensitivityGLYCOM AS·Filed 2020·Application pending·0 cites
- 3658US11419884B2Compositions comprising HMOS, their production and use for the prevention and/or treatment of viral and/or bacterial infectionsGLYCOM AS·Filed 2017·Granted Aug 23, 2022·0 cites·19 claims
- 3757US12233079B2Composition and method for treating humans using low-fodmap dietsGLYCOM AS·Filed 2019·Granted Feb 25, 2025·0 cites·13 claims
- 3857US11304966B2Composition comprising HMOs for preventing or reducing nociceptionGLYCOM AS·Filed 2018·Granted Apr 19, 2022·0 cites·22 claims
- 3954US2022054515A1Composition and method for promoting intestinal barrier healingGLYCOM AS·Filed 2019·Application pending·0 cites
- 4053US11524019B2Synthetic composition for reducing allergy symptomsGLYCOM AS·Filed 2018·Granted Dec 13, 2022·0 cites·18 claims
- 4153US2022378809A1Synthetic composition for balancing the bile acid profile in the intestineGLYCOM AS·Filed 2020·Application pending·0 cites
- 4251US12458052B2Human milk oligosaccharides for use in enhancing executive functionGLYCOM AS·Filed 2020·Granted Nov 4, 2025·0 cites·6 claims
- 4351US2020323921A1Human milk oligosaccharides and synthetic compositions thereof for microbiota modulationGLYCOM AS·Filed 2018·Application pending·0 cites
- 4450US2022249526A1Human milk oligosaccharides and compositions thereof for use in preventing, managing or treating symptoms related to migraineGLYCOM AS·Filed 2020·Application pending·0 cites
- 4549US11554131B2Mixture of HMOs for treating autoimmune diseasesGLYCOM AS·Filed 2019·Granted Jan 17, 2023·0 cites·20 claims
- 4649US2023338403A1Composition comprising 2'-fl and dfl for use in a method for reducing painGLYCOM AS·Filed 2019·Application pending·0 cites
- 4748US11602545B2Human milk oligosaccharides for treating migraineGLYCOM AS·Filed 2018·Granted Mar 14, 2023·0 cites·20 claims
- 4845US11541068B2HMO compositions and methods for reducing autism spectrum disorder symptomsGLYCOM AS·Filed 2018·Granted Jan 3, 2023·0 cites·20 claims
- 4945US11541067B2HMO compositions and methods for reducing detrimental proteolytic metabolitesGLYCOM AS·Filed 2018·Granted Jan 3, 2023·0 cites·18 claims
- 5043US2020138838A1Composition comprising hmss/hmos and use thereofGLYCOM AS·Filed 2019·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Louise Kristine Vigsnæs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →